(Q39871892)

15 September 2017

title

Projecting future drug expenditures--2010. (English)

1 reference

15 September 2017

7

Glen T Schumock

1 reference

15 September 2017

James M Hoffman

1

1 reference

15 September 2017

Fred Doloresco

2

1 reference

15 September 2017

Lee C Vermeulen

3

1 reference

15 September 2017

Nilay D Shah

4

1 reference

15 September 2017

Linda Matusiak

5

1 reference

15 September 2017

Robert J Hunkler

6

1 reference

15 September 2017

publication date

1 June 2010

1 reference

American Journal of Health-System Pharmacy

15 September 2017

published in

1 reference

15 September 2017

volume

67

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

919-928

1 reference

Health benefits in 2008: premiums moderately higher, while enrollment in consumer-directed plans rises in small firms

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Projecting future drug expenditures--2009.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

The demise of the blockbuster?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

31 March 2020

When the party's over

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

31 March 2020

2008 FDA drug approvals.

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

"Me-too" products--friend or foe?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Projecting future drug expenditures--2006.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

American Society of Clinical Oncology guidance statement: the cost of cancer care

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Bendamustine: rebirth of an old drug

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Health spending growth at a historic low in 2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

WHO guidelines presage US biosimilars legislation?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Health care reform and the need for comparative-effectiveness research

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Comparative effectiveness research: Relevance and applications to pharmacy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

Health care and the American Recovery and Reinvestment Act

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

ASHP guidelines on medication cost management strategies for hospitals and health systems

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP100068

31 March 2020

Identifiers

DOI

10.2146/AJHP100068

1 reference

15 September 2017

1 reference